Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

CLSCLS
8 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in CELESTICA INC

Yes. JPMorgan Chase holds 3,874,584 shares of CLS (Celestica), worth $1.3B, as of its Q2 2026 13F filing. It reduced the position by 576,209 shares (-13.0%) from Q1 2026. JPMorgan Chase has held CLS in every 13F on record since Q3 2024, 8 quarterly filings. CLS is 0.1% of JPMorgan Chase's reported 13F portfolio.

Current Value

$1.3B

Current Shares

3.9M

Total Value Change

+$1.3B

Total Shares Change

+3.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3.9M
-12.9%
$1.3B0.1%$364.80
0
2026-Q1
Increased
4.5M
+10.8%
$1.1B0.1%$281.68
35
2025-Q4
Increased
4M
+25.0%
$1.2B0.1%$295.61
39
2025-Q3
Increased
3.2M
+601.9%
$792M0.0%$246.38
51
2025-Q2
Increased
457,950
+1054.3%
$71.5M0.0%$156.11
48
2025-Q1
Decreased
39,673
-85.6%
$3.1M0.0%$78.81
0
2024-Q4
Increased
275,942
+14.9%
$25.5M0.0%$92.30
33
2024-Q3
First report
240,168
-
$12.3M0.0%$51.12
0

Other major holders of CLS: FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used